Analog specific aberrancies in antifolate inhibition of L1210 cell dihydrofolate reductase

Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2011

A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors.

Clinical cancer research : an official journal of the American Association for Cancer Research·2007

Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2007

A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors.

Cancer chemotherapy and pharmacology·2006

Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events.

Molecular carcinogenesis·2004

The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice, with a marked improvement in therapeutic index.

Clinical cancer research : an official journal of the American Association for Cancer Research·2003

Macrophage-intrinsic STAT3 drives LPS-induced acute lung injury: allosteric blockade by K116 and genetic validation via conditional knockout.

Biochemical pharmacology·2026

PARP1-targeting PROTAC attenuates alcohol-associated liver injury and ileal epithelial damage.

Biochemical pharmacology·2026

Celastrol induces mitochondrial apoptosis in hepatocellular carcinoma by suppressing LRP6-associated Wnt/β-catenin signaling.

Biochemical pharmacology·2026

Zinc gluconate attenuates oxaliplatin-induced pulmonary injury via suppressing the TLR4/NF-κB signaling.

Biochemical pharmacology·2026

Colchicine reduces aortic dissection and aneurysm formation in mice by inhibiting the IL-17A/RA-MAPK pathway.

Biochemical pharmacology·2026

RNF5: an emerging therapeutic target for modulating immunity and metabolism.

Biochemical pharmacology·2026

Mass Chlorfenapyr Poisoning: A Family Cluster Case Report.

Journal of emergency nursing·2026

Identification, Structure-Activity Relationship (SAR), and Biological Evaluation of New Chemical Series as Malaria Parasite PfGCN5 Bromodomain Inhibitors.

ACS omega·2026

Influences of 5-Hydroxytryptamine Receptor Agonists on Spermatozoal Hyperactivation and In Vitro Fertilization Success in Mice.

Reproductive medicine and biology·2026

Integrated molecular docking, simulation dynamics and cytotoxicity assays of Desmodium gangeticum-derived phytochemicals for multi-target cancer therapy.

In silico pharmacology·2026

Synthesis, Biological Evaluation, and Molecular Modeling of Novel Pyrimidine Scaffolds as Prospective Anticancer and Antimicrobial Agents.

ChemMedChem·2026

Revisiting molecular descriptors with TDiMS for interpretable intramolecular interactions based on substructure pairs.

Nature computational science·2026

Related Experiment Videos

Analog specific aberrancies in antifolate inhibition of L1210 cell dihydrofolate reductase

Related Concept Videos

Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trial.

A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors.

Phase II trial of pralatrexate (10-propargyl-10-deazaaminopterin, PDX) in patients with unresectable malignant pleural mesothelioma.

A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors.

Microarray analysis of prostate cancer progression to reduced androgen dependence: studies in unique models contrasts early and late molecular events.

The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates radiation response of human tumors in nude mice, with a marked improvement in therapeutic index.

Macrophage-intrinsic STAT3 drives LPS-induced acute lung injury: allosteric blockade by K116 and genetic validation via conditional knockout.

PARP1-targeting PROTAC attenuates alcohol-associated liver injury and ileal epithelial damage.

Celastrol induces mitochondrial apoptosis in hepatocellular carcinoma by suppressing LRP6-associated Wnt/β-catenin signaling.

Zinc gluconate attenuates oxaliplatin-induced pulmonary injury via suppressing the TLR4/NF-κB signaling.

Colchicine reduces aortic dissection and aneurysm formation in mice by inhibiting the IL-17A/RA-MAPK pathway.

RNF5: an emerging therapeutic target for modulating immunity and metabolism.

Mass Chlorfenapyr Poisoning: A Family Cluster Case Report.

Identification, Structure-Activity Relationship (SAR), and Biological Evaluation of New Chemical Series as Malaria Parasite PfGCN5 Bromodomain Inhibitors.

Influences of 5-Hydroxytryptamine Receptor Agonists on Spermatozoal Hyperactivation and In Vitro Fertilization Success in Mice.

Integrated molecular docking, simulation dynamics and cytotoxicity assays of Desmodium gangeticum-derived phytochemicals for multi-target cancer therapy.

Synthesis, Biological Evaluation, and Molecular Modeling of Novel Pyrimidine Scaffolds as Prospective Anticancer and Antimicrobial Agents.

Revisiting molecular descriptors with TDiMS for interpretable intramolecular interactions based on substructure pairs.

Related Experiment Videos

Analog specific aberrancies in antifolate inhibition of L1210 cell dihydrofolate reductase

Related Concept Videos

Related Articles